These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29779120)

  • 1. Discounting in Economic Evaluations.
    Attema AE; Brouwer WBF; Claxton K
    Pharmacoeconomics; 2018 Jul; 36(7):745-758. PubMed ID: 29779120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On discount rates for economic evaluations in global health.
    Haacker M; Hallett TB; Atun R
    Health Policy Plan; 2020 Feb; 35(1):107-114. PubMed ID: 31625564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discounting health effects in pharmacoeconomic evaluations: current controversies.
    Bos JM; Postma MJ; Annemans L
    Pharmacoeconomics; 2005; 23(7):639-49. PubMed ID: 16173156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The practice of discounting in economic evaluations of healthcare interventions.
    Smith DH; Gravelle H
    Int J Technol Assess Health Care; 2001; 17(2):236-43. PubMed ID: 11446135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discounting in the economic evaluation of health care interventions.
    Krahn M; Gafni A
    Med Care; 1993 May; 31(5):403-18. PubMed ID: 8501989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unequal discounting of health care costs and effects causes confusion].
    van Ballegooijen M; de Kok IM; Habbema JD
    Ned Tijdschr Geneeskd; 2010; 154():A1970. PubMed ID: 20619050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On discounting of health gains from human papillomavirus vaccination: effects of different approaches.
    Westra TA; Parouty M; Brouwer WB; Beutels PH; Rogoza RM; Rozenbaum MH; Daemen T; Wilschut JC; Boersma C; Postma MJ
    Value Health; 2012 May; 15(3):562-7. PubMed ID: 22583467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods of international health technology assessment agencies for economic evaluations--a comparative analysis.
    Mathes T; Jacobs E; Morfeld JC; Pieper D
    BMC Health Serv Res; 2013 Sep; 13():371. PubMed ID: 24079858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discounting in decision making: the consistency argument revisited empirically.
    Brouwer WB; van Exel NJ
    Health Policy; 2004 Feb; 67(2):187-94. PubMed ID: 14720636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allowing for differential timing in cost analyses: discounting and annualization.
    Walker D; Kumaranayake L
    Health Policy Plan; 2002 Mar; 17(1):112-8. PubMed ID: 11861593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discounting in economic evaluations: stepping forward towards optimal decision rules.
    Gravelle H; Brouwer W; Niessen L; Postma M; Rutten F
    Health Econ; 2007 Mar; 16(3):307-17. PubMed ID: 17006970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review.
    Jit M; Mibei W
    Vaccine; 2015 Jul; 33(32):3788-94. PubMed ID: 26144897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Productivity costs in economic evaluations: past, present, future.
    Krol M; Brouwer W; Rutten F
    Pharmacoeconomics; 2013 Jul; 31(7):537-49. PubMed ID: 23620213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: an issue for debate?
    Coyle D; Tolley K
    Pharmacoeconomics; 1992 Aug; 2(2):153-62. PubMed ID: 10146954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Handling time in economic evaluation studies.
    Permsuwan U; Guntawongwan K; Buddhawongsa P
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S50-8. PubMed ID: 24964699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical arguments for the discounting of health consequences: where do we go from here?
    Lazaro A
    Pharmacoeconomics; 2002; 20(14):943-61. PubMed ID: 12403636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic principles and methodological considerations of health economic evaluations].
    Loza C; Castillo-Portilla M; Rojas JL; Huayanay L
    Rev Peru Med Exp Salud Publica; 2011; 28(3):518-27. PubMed ID: 22086635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulating evidence for the case of differential discounting.
    Postma MJ; Parouty M; Westra TA
    Expert Rev Clin Pharmacol; 2013 Jan; 6(1):1-3. PubMed ID: 23272787
    [No Abstract]   [Full Text] [Related]  

  • 19. A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots.
    Khorasani E; Davari M; Kebriaeezadeh A; Fatemi F; Akbari Sari A; Varahrami V
    Eur J Health Econ; 2022 Dec; 23(9):1577-1590. PubMed ID: 35235078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discounting in cost-effectiveness analysis of healthcare programmes.
    Katz DA; Welch HG
    Pharmacoeconomics; 1993 Apr; 3(4):276-85. PubMed ID: 10146991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.